Sun Pharmaceutical Industries Q4 Results
- BSE: 524715
- NSE: SUNPHARMA
- ISIN: INE044A01036
- Sector: Biotechnology & Drugs
BSE
1,949
5.00 (0.26%)
5.00 (0.26%)Volume4.52 L
Updated: Fri 7 Aug, 2026 | 15:29:01
NSE
1,945
-6.00 (-0.31%)
-6.00 (-0.31%)Volume2.43 M
Updated: Fri 7 Aug, 2026 | 15:14:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Sun Pharmaceutical Industries Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 11,859.81 | 11,947.78 | -0.74% | 9,585.09 | 12.31% |
| Depreciation/ Amortization | 775.47 | 732.33 | 5.89% | 650.36 | 16.82% |
| Operating Income | 2,751.98 | 3,572.76 | -22.97% | 2,397.81 | 14.70% |
| Net Income | 2,714.03 | 3,368.81 | -19.44% | 2,654.58 | 26.24% |
| Other Operating Expenses Total | 5,322.84 | 4,888.87 | 8.88% | 4,093.41 | 20.75% |
| Net Income Before Taxes | 3,551.34 | 4,227.16 | -15.99% | 2,815.52 | 9.13% |
| Total Revenue | 14,611.79 | 15,520.54 | -5.86% | 11,982.90 | 12.76% |
| Selling/ General/ Admin Expenses Total | 2,960.41 | 2,892.00 | 2.37% | 2,360.72 | 18.96% |
| Diluted Normalized EPS | 11.50 | 14.15 | -18.74% | 11.56 | 15.50% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.